Morphine-3-glucuronide--a potent antagonist of morphine analgesia
In this study, morphine-3-glucuronide (M3G), the major plasma and urinary metabolite of morphine, was shown to be a potent antagonist of morphine analgesia when administered to rats by the intra-cerebroventricular (i.c.v.) route. The antagonism of morphine analgesia was observed irrespective of whet...
Saved in:
Published in | Life sciences (1973) Vol. 47; no. 6; p. 579 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
Netherlands
1990
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Abstract | In this study, morphine-3-glucuronide (M3G), the major plasma and urinary metabolite of morphine, was shown to be a potent antagonist of morphine analgesia when administered to rats by the intra-cerebroventricular (i.c.v.) route. The antagonism of morphine analgesia was observed irrespective of whether i.c.v. M3G (2.5 or 3.0 micrograms) was administered 15 mins prior to or 15 mins after i.c.v. morphine (20 micrograms). When M3G (10mg) was administered intraperitoneally (i.p.) to rats 30-40 mins prior to morphine (1.5mg i.p.), the analgesic response was significantly reduced compared to administration of morphine (1.5mg i.p.) alone. It was further demonstrated that i.c.v. M3G (2.0 micrograms) antagonized the analgesic effects of subsequently administered i.c.v. morphine-6-glucuronide (0.25 micrograms). |
---|---|
AbstractList | In this study, morphine-3-glucuronide (M3G), the major plasma and urinary metabolite of morphine, was shown to be a potent antagonist of morphine analgesia when administered to rats by the intra-cerebroventricular (i.c.v.) route. The antagonism of morphine analgesia was observed irrespective of whether i.c.v. M3G (2.5 or 3.0 micrograms) was administered 15 mins prior to or 15 mins after i.c.v. morphine (20 micrograms). When M3G (10mg) was administered intraperitoneally (i.p.) to rats 30-40 mins prior to morphine (1.5mg i.p.), the analgesic response was significantly reduced compared to administration of morphine (1.5mg i.p.) alone. It was further demonstrated that i.c.v. M3G (2.0 micrograms) antagonized the analgesic effects of subsequently administered i.c.v. morphine-6-glucuronide (0.25 micrograms). |
Author | Watt, J A Smith, M T Cramond, T |
Author_xml | – sequence: 1 givenname: M T surname: Smith fullname: Smith, M T organization: Department of Pharmacy, University of Queensland, St. Lucia, Australia – sequence: 2 givenname: J A surname: Watt fullname: Watt, J A – sequence: 3 givenname: T surname: Cramond fullname: Cramond, T |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/2402182$$D View this record in MEDLINE/PubMed |
BookMark | eNo9z0FLw0AQBeA9VGpb_QcKOephdXY2u5scS7EqVLzouUzS2RhJNiHZHPz3FgyeHnw8Hry1WIQusBA3Ch4UKPsIgKnUCOYuh_scrMqlXojVP1-K9Th-A4AxTi_FElNAleFKbN-6of-qA0stq2Yqp6EL9YmlpKTvIoeYUIhUnXGMSeeTdq6fmZqKx5quxIWnZuTrOTfic__0sXuRh_fn1932IEuduSid0ykooNI6tmyNsuggMwhgc08ZsrdoUqc1WUNlSpBj4RQXhXXeMCnciNu_3X4qWj4d-6Fuafg5zlfwFyj9SlQ |
CitedBy_id | crossref_primary_10_1300_J088v05n04_02 crossref_primary_10_1002_bmc_4066 crossref_primary_10_1016_0304_3959_93_90056_U crossref_primary_10_1016_S0304_3959_01_00376_1 crossref_primary_10_1111_bph_15792 crossref_primary_10_1111_j_2042_7158_1998_tb06176_x crossref_primary_10_1136_adc_69_1_Spec_No_55 crossref_primary_10_1007_s11095_010_0127_5 crossref_primary_10_1016_S0885_3924_01_00398_0 crossref_primary_10_1111_j_1365_2125_1992_tb04107_x crossref_primary_10_1007_s00210_007_0205_3 crossref_primary_10_1016_j_neuroscience_2012_12_013 crossref_primary_10_1016_j_jpainsymman_2007_04_023 crossref_primary_10_1016_S1570_0232_02_00726_2 crossref_primary_10_1542_peds_2004_2123 crossref_primary_10_1002_jps_1131 crossref_primary_10_1007_BF03257377 crossref_primary_10_1007_s40262_014_0135_4 crossref_primary_10_1016_j_pbb_2007_02_001 crossref_primary_10_1080_J354v16n04_02 crossref_primary_10_1089_jpm_2011_0502 crossref_primary_10_1016_S0024_3205_97_00364_0 crossref_primary_10_1016_0024_3205_94_00849_3 crossref_primary_10_1016_j_ejphar_2020_173021 crossref_primary_10_1016_S0378_4347_99_00041_9 crossref_primary_10_1016_S0889_8537_03_00055_5 crossref_primary_10_1111_j_1600_0773_1998_tb01398_x crossref_primary_10_1016_j_pbb_2006_04_021 crossref_primary_10_1097_00007691_199604000_00012 crossref_primary_10_1016_j_jpainsymman_2004_02_021 crossref_primary_10_1111_j_1365_2125_1995_tb05720_x crossref_primary_10_1016_0885_3924_95_00021_P crossref_primary_10_2165_00003088_200948060_00003 crossref_primary_10_1016_0006_2952_93_90659_K crossref_primary_10_1200_JCO_2001_19_11_2898 crossref_primary_10_1016_j_physbeh_2017_11_030 crossref_primary_10_1016_S1090_3801_97_90103_8 crossref_primary_10_1097_00001503_199810000_00016 crossref_primary_10_1111_j_1440_1681_1997_tb01202_x crossref_primary_10_1111_pan_12539 crossref_primary_10_1016_j_neubiorev_2015_01_022 crossref_primary_10_1111_j_1460_9592_2011_03536_x crossref_primary_10_3390_chromatography3010001 crossref_primary_10_3389_fnmol_2022_882443 crossref_primary_10_1111_j_1365_2710_1996_tb00002_x crossref_primary_10_1007_s00520_007_0368_y crossref_primary_10_1177_096032719801700611 crossref_primary_10_1016_S1471_7697_02_00006_0 crossref_primary_10_1016_0024_3205_94_90106_6 crossref_primary_10_1097_FTD_0000000000000763 crossref_primary_10_1111_j_1467_2995_1996_tb00278_x crossref_primary_10_1213_01_ANE_0000078220_83604_7E crossref_primary_10_1016_j_pain_2005_06_006 crossref_primary_10_1097_00002508_200305000_00005 crossref_primary_10_1007_BF02529688 crossref_primary_10_1016_0304_3959_93_90188_U crossref_primary_10_1080_J354v21n02_03 crossref_primary_10_1177_0269216311406313 crossref_primary_10_1016_S0024_3205_97_00919_3 crossref_primary_10_1016_0024_3205_94_90069_8 crossref_primary_10_1016_S0378_4347_00_00146_8 crossref_primary_10_1016_0014_2999_93_90441_J crossref_primary_10_1016_0140_6736_92_93067_W crossref_primary_10_1016_j_jamda_2018_07_009 crossref_primary_10_1208_s12248_015_9826_5 crossref_primary_10_1213_00000539_199901000_00021 crossref_primary_10_1177_0310057X170450S102 crossref_primary_10_1111_j_1600_0773_1996_tb00253_x crossref_primary_10_1186_1742_2094_9_200 crossref_primary_10_1016_0304_3959_95_00198_0 crossref_primary_10_1016_S0024_3205_99_00239_8 crossref_primary_10_1124_jpet_114_220764 crossref_primary_10_1016_S0091_3057_96_00471_6 crossref_primary_10_1016_S0024_3205_99_00110_1 crossref_primary_10_1007_s11096_010_9430_9 crossref_primary_10_1111_j_1399_6576_1997_tb04625_x crossref_primary_10_1002_ajh_21027 crossref_primary_10_1016_0024_3205_94_00552_4 crossref_primary_10_1016_S1090_3801_98_90004_0 crossref_primary_10_1124_dmd_31_3_326 crossref_primary_10_1007_BF00685556 crossref_primary_10_1016_0304_3959_94_90088_4 crossref_primary_10_1016_0304_3959_94_90065_5 crossref_primary_10_1111_j_1399_6576_1996_tb04417_x crossref_primary_10_1097_00001622_200007000_00006 crossref_primary_10_1016_0165_6147_92_90095_N crossref_primary_10_1016_0024_3205_95_02310_0 crossref_primary_10_1002_ddr_21785 crossref_primary_10_1002__SICI_1097_0142_19991101_86_9_1856__AID_CNCR30_3_0_CO_2_G crossref_primary_10_2131_jts_28_395 crossref_primary_10_1111_j_2042_7158_1996_tb03932_x crossref_primary_10_1016_j_cccn_2005_02_023 crossref_primary_10_1097_00002820_199808000_00011 crossref_primary_10_1300_J088v01n02_02 crossref_primary_10_1007_s11864_023_01117_9 crossref_primary_10_1016_S0731_7085_97_00094_0 crossref_primary_10_1016_S0378_4347_98_00438_1 crossref_primary_10_1097_00008571_200406000_00004 crossref_primary_10_1111_j_1600_0773_1995_tb01012_x crossref_primary_10_1053_sane_2002_34194 crossref_primary_10_1007_BF02938295 crossref_primary_10_1016_j_jpain_2010_10_012 crossref_primary_10_1186_2110_5820_2_3 crossref_primary_10_1006_phrs_1999_0528 crossref_primary_10_1016_0024_3205_94_00493_5 crossref_primary_10_1016_0379_0738_95_01833_6 crossref_primary_10_1111_j_1399_6576_1996_tb04467_x crossref_primary_10_1016_S0006_8993_00_02255_1 crossref_primary_10_1016_j_neuropharm_2003_11_024 crossref_primary_10_1016_0304_3959_93_90129_D crossref_primary_10_1111_j_1600_0773_1994_tb00327_x crossref_primary_10_1016_j_bpa_2006_12_004 crossref_primary_10_1016_S0749_0704_02_00004_0 crossref_primary_10_1016_S0196_9781_96_00215_X crossref_primary_10_1016_0885_3924_94_00121_Z crossref_primary_10_1016_S0885_3924_97_00020_1 crossref_primary_10_1097_00000539_199901000_00021 crossref_primary_10_1097_01_ajp_0000210925_33783_4d crossref_primary_10_1111_j_1476_5381_1995_tb16307_x crossref_primary_10_1097_PCC_0000000000002873 crossref_primary_10_1111_j_1476_5381_1993_tb13802_x crossref_primary_10_1111_j_1399_6576_1997_tb04630_x crossref_primary_10_1046_j_1525_1403_2001_00025_x crossref_primary_10_1124_jpet_102_035626 crossref_primary_10_1016_j_siny_2004_11_002 crossref_primary_10_1089_omi_2016_0105 crossref_primary_10_1111_j_1399_6576_1998_tb05378_x crossref_primary_10_1152_ajpregu_00824_2005 crossref_primary_10_1111_j_1399_6576_1997_tb04604_x crossref_primary_10_2165_00148581_200911020_00004 crossref_primary_10_1016_j_jpba_2005_04_049 crossref_primary_10_1016_S0024_3205_98_00288_4 crossref_primary_10_1007_BF02527887 crossref_primary_10_1007_s40262_017_0544_2 crossref_primary_10_1300_J088v06n01_02 crossref_primary_10_1016_j_neuro_2004_12_011 crossref_primary_10_1111_j_1600_0773_1996_tb00239_x crossref_primary_10_1542_peds_2004_1425 crossref_primary_10_1016_S0749_0704_18_30042_3 crossref_primary_10_1016_0304_3959_94_00228_7 crossref_primary_10_1007_BF03259602 crossref_primary_10_1213_01_ANE_0000068482_67289_1A crossref_primary_10_1016_j_ejogrb_2006_07_038 crossref_primary_10_1007_s11916_998_0010_9 crossref_primary_10_1016_0361_9230_95_00104_M crossref_primary_10_1016_S1636_6522_05_81561_2 crossref_primary_10_1073_pnas_0502530102 crossref_primary_10_1002_bmc_3957 crossref_primary_10_1093_bja_aeu186 crossref_primary_10_1016_S1090_3801_99_90189_1 crossref_primary_10_1016_0304_3959_93_90232_E crossref_primary_10_1046_j_1440_1681_2000_03293_x crossref_primary_10_1016_j_bmcl_2010_08_098 crossref_primary_10_1136_bmj_306_6880_793_d crossref_primary_10_1136_bmj_306_6880_793_a crossref_primary_10_1046_j_1365_2125_2000_00141_x crossref_primary_10_1111_j_1365_2125_2005_02573_x crossref_primary_10_1002_hlca_19980810214 crossref_primary_10_1016_j_bmcl_2003_12_016 crossref_primary_10_1136_bmj_306_6880_793_c crossref_primary_10_1136_bmj_306_6880_793_b crossref_primary_10_1177_026921639400800209 crossref_primary_10_1016_S0304_3940_00_00796_5 crossref_primary_10_1111_j_1460_9592_2011_03737_x crossref_primary_10_1213_ANE_0000000000000936 crossref_primary_10_4236_ojmip_2013_34022 crossref_primary_10_1146_annurev_biochem_73_011303_073940 crossref_primary_10_1016_0304_3959_92_90023_5 crossref_primary_10_1007_BF02353460 crossref_primary_10_1016_S0304_3959_97_00142_5 crossref_primary_10_1016_j_ejphar_2018_07_018 crossref_primary_10_1016_S0885_3924_02_00531_6 crossref_primary_10_1046_j_1440_1681_2000_03206_x crossref_primary_10_2165_00003495_200161070_00005 crossref_primary_10_1002_j_1552_4604_1995_tb04743_x crossref_primary_10_1007_BF02479958 crossref_primary_10_1007_s00228_006_0195_y crossref_primary_10_1007_BF02178565 crossref_primary_10_1039_NP9920900365 crossref_primary_10_1016_0024_3205_94_00631_8 crossref_primary_10_4236_ojmip_2013_33019 crossref_primary_10_1016_0006_8993_96_00205_3 crossref_primary_10_1016_S0163_7258_00_00090_5 crossref_primary_10_1002__SICI_1097_0142_19980315_82_6_1167__AID_CNCR23_3_0_CO_2_3 crossref_primary_10_1016_j_jclinane_2005_03_004 crossref_primary_10_1136_bmj_306_6880_793 crossref_primary_10_1097_00007691_199804000_00013 crossref_primary_10_1016_j_acpain_2006_11_001 crossref_primary_10_1002__SICI_1097_0142_19970401_79_7_1428__AID_CNCR21_3_0_CO_2_0 crossref_primary_10_1016_j_pbb_2020_173022 crossref_primary_10_1016_j_pbb_2009_03_013 crossref_primary_10_1111_j_1365_2125_1992_tb05651_x crossref_primary_10_1002_jlcr_1875 crossref_primary_10_1016_0006_8993_95_00697_O crossref_primary_10_1016_0304_3959_96_03112_0 crossref_primary_10_1111_j_1742_7843_2009_00451_x crossref_primary_10_1111_j_1476_5381_1995_tb15125_x crossref_primary_10_1191_026921699678158579 crossref_primary_10_1002_med_20035 crossref_primary_10_1016_S0378_5173_97_00381_5 crossref_primary_10_1016_0006_2952_93_90462_6 crossref_primary_10_1111_j_1533_2500_2007_00119_x crossref_primary_10_1345_aph_1R784 crossref_primary_10_1016_S0304_3959_96_03102_8 crossref_primary_10_1124_dmd_31_5_677 crossref_primary_10_1016_0024_3205_95_00311_S crossref_primary_10_1053_eujp_2001_0307 crossref_primary_10_1002_dta_2492 crossref_primary_10_1016_j_arcped_2005_12_007 crossref_primary_10_1046_j_1365_2125_2003_01794_x crossref_primary_10_1136_bmj_306_6876_473 crossref_primary_10_1191_0269216302pm512oa crossref_primary_10_1016_S0006_2952_97_00086_5 crossref_primary_10_2165_00003088_200645070_00005 crossref_primary_10_1016_j_vaa_2022_07_006 crossref_primary_10_1016_0304_3959_94_90084_1 crossref_primary_10_1016_j_ejpain_2004_01_007 crossref_primary_10_1016_0304_3959_94_00268_J crossref_primary_10_1007_s00253_022_11789_2 crossref_primary_10_1016_S1090_3801_97_90074_4 crossref_primary_10_1021_js980056f crossref_primary_10_1007_s00520_003_0440_1 crossref_primary_10_1016_S0091_3057_02_00925_5 crossref_primary_10_1111_j_1365_2125_2012_04201_x crossref_primary_10_1016_j_pharmthera_2022_108312 crossref_primary_10_1186_s12917_020_2242_9 crossref_primary_10_1016_S0378_5173_97_00380_3 crossref_primary_10_3109_03602539608994011 crossref_primary_10_1124_jpet_105_094276 crossref_primary_10_1016_j_jpainsymman_2012_03_015 crossref_primary_10_1097_00007691_199810000_00020 crossref_primary_10_1111_j_1440_1681_2008_05019_x crossref_primary_10_1016_j_ejps_2015_03_020 crossref_primary_10_1186_1472_6904_4_7 crossref_primary_10_1002_bdd_2510140102 crossref_primary_10_1016_S0378_3782_00_00082_7 |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM |
DOI | 10.1016/0024-3205(90)90619-3 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
Discipline | Sciences (General) Biology |
ExternalDocumentID | 2402182 |
Genre | Journal Article |
GroupedDBID | --- --K --M -~X .55 .GJ .~1 0R~ 1B1 1RT 1~. 29L 3O- 4.4 457 53G 5GY 5RE 5VS 6TJ 7-5 71M 8P~ 9JM AABNK AACTN AAEDT AAEDW AAHBH AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AAXKI AAXUO ABFNM ABFRF ABJNI ABLJU ABMAC ABMZM ABTAH ABXDB ABZDS ACDAQ ACGFO ACGFS ACIUM ACIWK ACPRK ACRLP ADBBV ADEZE ADMUD AEBSH AEFWE AEKER AENEX AFFNX AFJKZ AFKWA AFRAH AFTJW AFXIZ AGHFR AGUBO AGYEJ AHHHB AIEXJ AIKHN AITUG AJOXV AJRQY AKRWK ALCLG ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV C45 CGR CNWQP CS3 CUY CVF DU5 EBS ECM EFJIC EIF EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HMG HMT HVGLF HZ~ H~9 IH2 IHE J1W J5H K-O KOM L7B M34 M41 MO0 MVM N9A NPM O-L O9- OAUVE OGGZJ OVD OZT P-8 P-9 P2P PC. Q38 R2- RIG ROL RPZ SDF SDG SDP SES SEW SIN SPCBC SPT SSH SSP SSZ T5K TEORI WUQ X7M Y6R YYP YZZ ZGI ZKB ZXP ZY4 ~G- |
ID | FETCH-LOGICAL-c387t-7734010ac67e6e65162708520069fa82ef6254733a65ac4a092b71ebb67f5ea12 |
ISSN | 0024-3205 |
IngestDate | Sat Sep 28 08:39:08 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c387t-7734010ac67e6e65162708520069fa82ef6254733a65ac4a092b71ebb67f5ea12 |
PMID | 2402182 |
ParticipantIDs | pubmed_primary_2402182 |
PublicationCentury | 1900 |
PublicationDate | 1990-00-00 |
PublicationDateYYYYMMDD | 1990-01-01 |
PublicationDate_xml | – year: 1990 text: 1990-00-00 |
PublicationDecade | 1990 |
PublicationPlace | Netherlands |
PublicationPlace_xml | – name: Netherlands |
PublicationTitle | Life sciences (1973) |
PublicationTitleAlternate | Life Sci |
PublicationYear | 1990 |
SSID | ssj0005573 |
Score | 1.8210573 |
Snippet | In this study, morphine-3-glucuronide (M3G), the major plasma and urinary metabolite of morphine, was shown to be a potent antagonist of morphine analgesia... |
SourceID | pubmed |
SourceType | Index Database |
StartPage | 579 |
SubjectTerms | Analgesia Animals Drug Administration Routes Male Morphine - administration & dosage Morphine - antagonists & inhibitors Morphine Derivatives - antagonists & inhibitors Morphine Derivatives - pharmacology Pain Measurement - drug effects Rats Rats, Inbred Strains |
Title | Morphine-3-glucuronide--a potent antagonist of morphine analgesia |
URI | https://www.ncbi.nlm.nih.gov/pubmed/2402182 |
Volume | 47 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LS8MwGA8-ELyIT3zTg4PJiLZpmrTHIYqI22lDbyNP8OA2dB70r_dLk7XFF-qllKQNJb-vX773h9CJLrRSRnOsuSKYipxiqaTEkgpLREGZLuts9_rsekhv7rP7usdmmV0yk2fq7cu8kv-gCmOAq8uS_QOy1aIwAPeAL1wBYbj-CuPeBHYJxESclqHnL67OrTYYi850MvPB487p5Irjln708DgMu-4ezw-iKZrePljTCQeir99U8KYZtrLB9OrA6jsRfEu1SfTiyfUv0nX8tQ45dnHDpDAP8ac4JXHWZJO-MGYghybPy3w3mE-82JsFqrVazqXZcqcf6Gw4bb4Cuzp9LDFyvp7EdyP6cfJDjewws4gWee7YXN-ZbOZxPlkIMwjfMc-fTNh5NdYu4tPwXatoJaz2QdEoBY7BOloLmkLU9bBvoAUz3kQrvnfo6ybaCFz5OWqH0uGnW6j7LUVEniKimiKiiY3mFBFVFLGNhleXg4trHJpkYJXmfAbaUQoqciwU44YZliWMcBCjnaWosCInxoKGS3maCpYJRUVcEMkTIyXjNjMiITtoaTwZm10UgXBpSKZZTFNLZSIKayWchcS56otE5Xtox2_IaOoroYzCTu1_N3GAVmv6OkTLFn48cwRS3Ewelyi9AyhnPQw |
link.rule.ids | 786 |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Morphine-3-glucuronide--a+potent+antagonist+of+morphine+analgesia&rft.jtitle=Life+sciences+%281973%29&rft.au=Smith%2C+M+T&rft.au=Watt%2C+J+A&rft.au=Cramond%2C+T&rft.date=1990-01-01&rft.issn=0024-3205&rft.volume=47&rft.issue=6&rft.spage=579&rft_id=info:doi/10.1016%2F0024-3205%2890%2990619-3&rft_id=info%3Apmid%2F2402182&rft_id=info%3Apmid%2F2402182&rft.externalDocID=2402182 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0024-3205&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0024-3205&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0024-3205&client=summon |